Company intelligence / Profile preview

ForQaly Medical

Shanghai, Shanghai, Chinascoop.co.nz ↗

Ownership: Private
Employees: ~100
Development stage: Preclinical

Overview

ForQaly Medical is a leading Chinese developer of minimally invasive ventricular assist devices. Its flagship product, the SynFlow® percutaneous transvalvular ventricular assist system, is among the first domestically developed interventional VADs in China. The company has completed Series B financing to advance clinical research and expand its R&D team. Clinical data collection and pre-clinical training are ongoing to support regulatory approval and commercialization.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Legend Capital

Beyond the preview

Go deeper on ForQaly Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ForQaly Medical.

Explore the full profile